ODYSSEY MARINE EXPLORATION (OMEX)

US6761182012 - Common Stock

3.63  -0.24 (-6.2%)

After market: 3.6681 +0.04 (+1.05%)

Fundamental Rating

1

OMEX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. OMEX may be in some trouble as it scores bad on both profitability and health. OMEX has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

OMEX had positive earnings in the past year.
OMEX had a negative operating cash flow in the past year.
OMEX had negative earnings in each of the past 5 years.
OMEX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

OMEX has a Return On Assets of 4.65%. This is in the better half of the industry: OMEX outperforms 75.90% of its industry peers.
Industry RankSector Rank
ROA 4.65%
ROE N/A
ROIC N/A
ROA(3y)-137.32%
ROA(5y)-140.47%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 58.56%, OMEX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
OMEX does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 58.56%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

OMEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OMEX has been increased compared to 1 year ago.
OMEX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OMEX has an improved debt to assets ratio.

2.2 Solvency

OMEX has an Altman-Z score of -33.55. This is a bad value and indicates that OMEX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -33.55, OMEX is not doing good in the industry: 98.80% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -33.55
ROIC/WACCN/A
WACC6.49%

2.3 Liquidity

OMEX has a Current Ratio of 0.11. This is a bad value and indicates that OMEX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.11, OMEX is doing worse than 96.39% of the companies in the same industry.
A Quick Ratio of 0.11 indicates that OMEX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.11, OMEX is doing worse than 96.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.71% over the past year.
The Revenue has decreased by -2.63% in the past year.
Measured over the past years, OMEX shows a small growth in Revenue. The Revenue has been growing by 1.25% on average per year.
EPS 1Y (TTM)101.71%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q3.33%
Revenue 1Y (TTM)-2.63%
Revenue growth 3Y-24.33%
Revenue growth 5Y1.25%
Revenue growth Q2Q-56.41%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y22.5%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 181.50, the valuation of OMEX can be described as expensive.
Based on the Price/Earnings ratio, OMEX is valued a bit more expensive than the industry average as 61.45% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 25.20, OMEX is valued quite expensively.
OMEX is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 181.5
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)8.07
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for OMEX!.
Industry RankSector Rank
Dividend Yield N/A

ODYSSEY MARINE EXPLORATION

NASDAQ:OMEX (4/23/2024, 7:17:11 PM)

After market: 3.6681 +0.04 (+1.05%)

3.63

-0.24 (-6.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap72.53M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 181.5
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)8.07
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.65%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 58.56%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)101.71%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y22.5%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.63%
Revenue growth 3Y-24.33%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y